# Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer

> **NCT00492778** · PHASE2 · UNKNOWN · sponsor: **GOG Foundation** · enrollment: 165 (actual)

## Conditions studied

- Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation
- Endometrial Mucinous Adenocarcinoma
- Endometrial Squamous Cell Carcinoma
- Recurrent Endometrial Clear Cell Adenocarcinoma
- Recurrent Endometrial Endometrioid Adenocarcinoma
- Recurrent Endometrial Serous Adenocarcinoma
- Recurrent Endometrial Undifferentiated Carcinoma
- Recurrent Uterine Corpus Cancer

## Interventions

- **RADIATION:** 3-Dimensional Conformal Radiation Therapy
- **DRUG:** Cisplatin
- **RADIATION:** Intensity-Modulated Radiation Therapy
- **RADIATION:** Internal Radiation Therapy

## Key facts

- **NCT ID:** NCT00492778
- **Lead sponsor:** GOG Foundation
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-02-25
- **Primary completion:** 2021-12-15
- **Final completion:** —
- **Target enrollment:** 165 (ACTUAL)
- **Last updated:** 2023-03-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00492778

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00492778, "Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00492778. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*